January 28, 2012
Harel Z, Gilbert C, Wald R, Bell C, Perl J, Juurlink D, Beyene J, Shah PS. BMJ. 2012 Jan 9;344:e42
In the wake of the termination of the Altitude study, this meta-analysis identifies an increase risk of hyperkalemia but not acute kidney injury in the combination of aliskiren and angiotensin converting enzyme inhibitors or angiotensin receptor blockers.
November 1, 2010
Elliott MJ, Ronksley PE, Clase CM, Ahmed SB, Hemmelgarn BR. CMAJ. 2010 Oct 19;182(15):1631-5
This case-based systematic review nicely summarizes the available therapeutic options for management of acute hyperkalemia.
July 20, 2010
Antoniou T, Gomes T, Juurlink DN, Loutfy MR, Glazier RH, Mamdani MM. Arch Intern Med. 2010 Jun 28;170(12):1045-9
This case control study suggests that older patients taking ACEIs or ARBs have a major increase in the risk of hyperkalemia-associated hospitalization when using trimethoprim-sulfamethoxazole.
February 12, 2010
Hoorn EJ, Zietse R. NDT Plus. 2010 Feb;3(1):42-44
November 22, 2009
Nyirenda MJ, Tang JI, Padfield PL, Seckl JR. BMJ. 2009 Oct 23;339:b4114
An up to date clinical review on hyperkalemia.
November 1, 2008
Pitt B, Bakris G, Ruilope LM, DiCarlo L, Mukherjee R, EPHESUS Investigators. Circulation. 2008 Oct 14;118(16):1643-50
September 1, 2008
LeGrand SB, Leskuski D, Zama I. Ann Intern Med. 2008 Aug 19;149(4):259-63
March 1, 2008
Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA. Arch Intern Med. 2008 Jan 14;168(1):80-5
February 1, 2008
Brimioulle S, Orellana-Jimenez C, Aminian A, Vincent JL. Intensive Care Med. 2008 Jan;34(1):125-31
December 1, 2007
Yakupoglu HY, Corsenca A, Wahl P, Wüthrich RP, Ambühl PM. Transplantation. 2007 Nov 15;84(9):1151-7
November 1, 2007
Mohmand HK, Issa D, Ahmad Z, Cappuccio JD, Kouides RW, Sterns RH. Clin J Am Soc Nephrol. 2007 Nov;2(6):1110-7
October 1, 2007
Zar T, Yusufzai I, Sullivan A, Graeber C. Nat Clin Pract Nephrol. 2007 Sep;3(9):515-20
Recent Comments